Evidence map›Paper›PMID 41557841›Full record

ArticleBioinformatics (Oxford, England)2026

inMOTIFin: a lightweight end-to-end simulation software for regulatory sequences.

Katalin Ferenc, Lorenzo Martini, Ieva Rauluseviciute, Geir Kjetil Ferkingstad Sandve, Anthony Mathelier

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katalin FerencNorwegian Centre for Molecular Biosciences and Medicine (NCMBM), Nordic EMBL Partnership, University of Oslo, Oslo 0318, Norway.ORCID 0000-0002-3006-4297
Lorenzo MartiniNorwegian Centre for Molecular Biosciences and Medicine (NCMBM), Nordic EMBL Partnership, University of Oslo, Oslo 0318, Norway.ORCID 0000-0002-7794-7791
Ieva RauluseviciuteNorwegian Centre for Molecular Biosciences and Medicine (NCMBM), Nordic EMBL Partnership, University of Oslo, Oslo 0318, Norway.ORCID 0000-0001-9253-8825
Geir Kjetil Ferkingstad SandveDepartment of Informatics, University of Oslo, Oslo, 0373, Norway.ORCID 0000-0002-4959-1409
Anthony MathelierNorwegian Centre for Molecular Biosciences and Medicine (NCMBM), Nordic EMBL Partnership, University of Oslo, Oslo 0318, Norway.ORCID 0000-0001-5127-5459

Funding

Helse Sør-ØstNorwegian Cancer Society 272930Research Council of Norway 187615University of Oslo through the Norwegian Centre for Molecular Biosciences and MedicineWellcome Trust 215027
6 · The paper itself

Abstract

summaryThe accurate development, assessment, interpretation, and benchmarking of bioinformatics frameworks for analyzing transcriptional regulatory grammars rely on controlled simulations to validate the underlying methods. However, existing simulators often lack end-to-end flexibility or ease of integration, which limits their practical use. We present inMOTIFin, a lightweight, modular, and user-friendly Python-based software that addresses these gaps by providing versatile and efficient simulation and modification of DNA regulatory sequences. inMOTIFin enables users to simulate or modify regulatory sequences efficiently for the customizable generation of motifs and insertion of motif instances with precise control over their positions, co-occurrences, and spacing, as well as direct modification of real sequences, facilitating a comprehensive evaluation of motif-based methods and interpretation tools. We demonstrate inMOTIFin applications for the assessment of de novo motif discovery, the analysis of transcription factor cooperativity, and the support of explainability analyses for deep learning models. inMOTIFin ensures robust and reproducible analyses for studying transcriptional regulatory grammars. AVAILABILITY AND IMPLEMENTATION: inMOTIFin is available at PyPI https://pypi.org/project/inMOTIFin/ and Docker Hub https://hub.docker.com/r/cbgr/inmotifin. Detailed documentation is available at https://inmotifin.readthedocs.io/en/latest/. The code for use case analyses is available at https://bitbucket.org/CBGR/inmotifin_evaluation/src/main/. The version of the code used for this article has been uploaded to Zenodo with DOI: 10.5281/zenodo.17638579.

Indexed as

Computational BiologyRegulatory Sequences, Nucleic AcidSoftwareComputer SimulationNucleotide MotifsSequence Analysis, DNATranscription FactorsTranscription Factors

Identifiers

PMID41557841
PMCPMC12881827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.